Program
NNC0471-0119
A development code. Also written as “NNC0471-0119 H”, “NNC0471-0119 A” and “NNC0471-0119 B”.
Its studies are mostly in Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 2, led by Novo Nordisk.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Novo Nordisk | 40 open or running | phase 1since Oct 28, 2020 | Oct 28, 2020 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Oct 28, 2020First study: phase 1 study in Diabetes Mellitus, Type 1First studyNCT04655690 · 48 enrolled · Austria
- Feb 21, 2022Phase 1 study in Diabetes Mellitus, Type 1NCT05262595 · 19 enrolled · Austria
- Jan 30, 2025Phase 1 study in Diabetes Mellitus, Type 1NCT06809621 · 43 enrolled · Germany
- Jul 7, 2025Phase 1 study in Diabetes Mellitus, Type 2NCT07068295 · 65 enrolled · Germany
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07068295Diabetes Mellitus, Type 2 · Germany | 1 | Completed | Feb 22, 2026 | 65 |
| NCT06809621Diabetes Mellitus, Type 1 · Germany | 1 | Completed | Jul 16, 2025 | 43 |
| NCT05262595Diabetes Mellitus, Type 1 · Austria | 1 | Completed | Aug 29, 2022 | 19 |
| NCT04655690Diabetes Mellitus, Type 1 · Austria | 1 | Completed | Nov 26, 2021 | 48 |
How it is read
Names in the registry
- “NNC0471-0119 H”, 2 entries
- “NNC0471-0119 A”, 1 entry
- “NNC0471-0119 B”, 1 entry
- “NNC0471-0119 D”, 1 entry
- “NNC0471-0119”, 1 entry
Codes read as this program: NNC04710119.
Conditions, from the studies’ own filings
- Diabetes Mellitus, Type 1, 3 studies
- Diabetes Mellitus, Type 2, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.